An interventional study of Nutrition Education and Physical Activity Education in Celiac Disease, Celiac Disease in Children and Celiac Disease in Adolescents, sponsored by Bahçeşehir University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 8 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-06.
Sponsored by Bahçeşehir University · Not applicable, Interventional, and Prevention
Among 13 studies in Celiac Disease with a site in Turkey — 3 open to participants now, 4 under way, none of them phase 3. Celiac Disease · Turkey.
Among the 13 studies in Celiac Disease with a site in Turkey, this one is one of 3 that started in 2026, is one of 6 with no phase, and was the 12th registered.
352 studies on the registry are indexed under Celiac Disease; 77 are open to participants now.
This study's planned enrollment of 54 is close to the median of 50 across 214 interventional studies indexed under Celiac Disease.
Browse Celiac Disease studies →3 of the 13 studies in Celiac Disease with a site in Turkey are open now, in 1 country. Each count lists the studies.
Of the 48 Celiac Disease studies recruiting now, 24 (50%) set no upper age limit and 19 (40%) stop at 75 or younger; 16 take children under 18; 13 take healthy volunteers.
This study: 8 Years to 12 Years · all sexes · no healthy volunteers.
The full table on the hub →13 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 3 started in 2026.
Median enrollment 54 across the 7 interventional studies, 56 across the 6 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
1 of 13 have an industry lead sponsor. The 10 most frequent:
Bahçeşehir University is the lead sponsor of 128 studies on the registry; 26 are open to participants now.
Bahçeşehir University has 1 study filed under Celiac Disease — fewer than ten, so there is no comparison to draw.
2 of the studies in Celiac Disease with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07750795Bahçeşehir UniversityNutrition and Physical Activity Education in Children With Celiac Disease | 2027-01-01 |
| NCT07382999Inonu UniversityEffect of Adherence to a Gluten-Free Diet on Cognitive and Motor Dual-Task Performance in Adolescents Diagnosed With Celiac Disease | 2027-01-15 |
Among the 13 studies in Celiac Disease with a site in Turkey, from their registry updates:
Celiac disease is a chronic immune-mediated disorder that requires lifelong adherence to a gluten-free diet. Despite dietary treatment, children with celiac disease may experience nutritional inadequacies, unhealthy eating behaviors, reduced physical activity, and impaired quality of life. This randomized, single-blind, controlled trial aims to evaluate the effects of a structured nutrition education program combined with physical activity education on anthropometric measurements, eating behavior, physical activity, and health-related quality of life in children aged 8-12 years with celiac disease. Fifty-four participants will be randomly assigned to one of three groups: (1) nutrition and physical activity education, (2) physical activity education only, or (3) no education (control). Outcomes will be assessed at baseline and after a 6-week follow-up using validated questionnaires, anthropometric measurements, body composition analysis, and physical performance tests. The findings are expected to provide evidence for multidisciplinary educational interventions to improve the health and well-being of children with celiac disease.
Celiac disease is a chronic immune-mediated enteropathy triggered by gluten ingestion in genetically susceptible individuals. Lifelong adherence to a strict gluten-free diet is currently the only effective treatment. Although a gluten-free diet promotes intestinal healing, many children with celiac disease continue to experience nutritional inadequacies due to the frequent consumption of highly processed gluten-free products, which are often high in sugar and saturated fat while being low in dietary fiber and essential micronutrients. These dietary patterns may negatively affect growth, body composition, eating behaviors, and long-term health outcomes.
Children with celiac disease may also exhibit lower levels of physical activity, reduced muscle strength, decreased bone mineralization, and diminished quality of life. Previous studies have suggested beneficial effects of nutrition education and physical activity separately; however, evidence regarding the effectiveness of a multidisciplinary intervention combining both approaches in pediatric patients with celiac disease remains limited.
This study is a single-blind, randomized, controlled trial designed to evaluate the effectiveness of a structured nutrition education program combined with physical activity education in children with celiac disease. A total of 54 children aged 8 to 12 years who have been following a gluten-free diet for at least six months will be randomly allocated into one of three study groups: (1) nutrition education plus physical activity education, (2) physical activity education only, or (3) a control group receiving no education during the intervention period. Participants will be followed for six weeks.
Baseline and post-intervention assessments will include anthropometric measurements, body composition analysis using bioelectrical impedance analysis, dietary assessment, eating behavior, health-related quality of life, physical activity level, lower extremity muscle strength, flexibility, and objective monitoring of daily physical activity using wearable activity trackers. Nutrition education will focus on healthy gluten-free dietary choices, reducing consumption of ultra-processed gluten-free foods, preventing cross-contamination, and promoting balanced eating habits. The physical activity education program will include supervised instruction on strengthening, aerobic, flexibility, balance, and coordination exercises, supported by educational materials and weekly online follow-up sessions.
The primary objective is to determine whether a combined nutrition and physical activity education program improves anthropometric measurements, eating behavior, physical activity, and health-related quality of life compared with physical activity education alone or usual care. The findings are expected to provide evidence supporting multidisciplinary educational interventions for improving health outcomes in children with celiac disease and contribute to the development of pediatric lifestyle management strategies.
Inclusion Criteria Children aged 8 to 12 years (inclusive). Clinically diagnosed with celiac disease. Following a gluten-free diet for at least 6 months before enrollment. Able to understand study instructions and complete study assessments. Parent or legal guardian able to provide written . Child able to provide assent to participate. Exclusion Criteria Following a gluten-free diet for reasons other than celiac disease. Age younger than 8 years or older than 12 years. Refusal or inability of the parent/legal guardian to provide informed consent or of the child to provide assent.
Any physical disability or medical condition that would limit participation in the physical activity program.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to this group will receive a structured nutrition education session and a physical activity education program. Nutrition education will focus on healthy gluten-free dietary practices, reducing the consumption of packaged and ultra-processed gluten-free foods, preventing cross-contamination, and promoting balanced nutrition. Physical activity education will include supervised instruction on strengthening, aerobic, flexibility, balance, and coordination exercises. Participants will be followed for 6 weeks with weekly online support sessions.
Behavioral: Nutrition Education · Behavioral: Physical Activity Education
A structured physical activity education program including supervised instruction on strengthening, aerobic, balance, flexibility, and coordination exercises. Participants will receive educational materials and weekly online follow-up to encourage adherence throughout the 6-week intervention period.
Behavioral: Physical Activity Education
Participants assigned to the control group will not receive nutrition or physical activity education during the 6-week intervention period. They will complete the same baseline and post-intervention assessments as the intervention groups. After completion of the study, participants who wish to receive the educational program will be offered the intervention.
Participants will receive a one-session structured nutrition education program focusing on healthy gluten-free dietary practices. The education will include information on gluten-containing foods, prevention of cross-contamination, healthy naturally gluten-free alternatives, reducing packaged and ultra-processed gluten-free food consumption, food label reading, and balanced meal planning. Participants will receive educational materials and will be followed weekly online for 6 weeks to reinforce the educational content.
Participants will receive a structured physical activity education program consisting of one educational session followed by a 6-week home-based exercise program. The program includes aerobic, strengthening, balance, flexibility, and coordination exercises performed twice weekly, supported by an exercise booklet and weekly online follow-up sessions to encourage adherence.
Change in eating behavior score
Eating behavior will be assessed using the Children's Eating Behavior Scale, a validated 19-item questionnaire consisting of five subdomains (Family, Skills, Negativity, Emotion, and Permission). Each item is rated on a 5-point Likert scale, and the mean total score will be calculated. Higher scores indicate greater expression of the assessed eating behavior characteristics. Changes in the total eating behavior score from baseline to Week 6 will be compared between the study groups.
Time frame: Baseline and week 6
Change in packaged gluten-free food consumption frequency
Packaged gluten-free food consumption frequency will be assessed using a researcher-developed food frequency questionnaire. The questionnaire evaluates the frequency of consumption of packaged gluten-free products and naturally gluten-free foods. Changes in consumption frequency from baseline to Week 6 will be compared between the study groups.
Time frame: Baseline and Week 6
Change in physical activity level
Physical activity level will be assessed using the Physical Activity Questionnaire for Children (PAQ-C). The questionnaire evaluates habitual physical activity during the previous 7 days. Higher scores indicate higher physical activity levels.
Time frame: Baseline and Week 6
Change in health-related quality of life
Health-related quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL 4.0), a validated 23-item questionnaire evaluating physical, emotional, social, and school functioning. Scores range from 0 to 100, with higher scores indicating better health-related quality of life. Changes in total and domain scores from baseline to Week 6 will be compared between the study groups.
Time frame: Baseline and Week 6
Change in daily step count
Daily physical activity will be objectively assessed using wearable activity trackers. The average daily step count recorded during the intervention period will be compared between the study groups.
Time frame: Baseline and Week 6
Change in body mass index-for-age z-score
Body mass index (BMI)-for-age z-score will be calculated according to the World Health Organization growth standards using standardized anthropometric measurements obtained at baseline and Week 6.
Time frame: Baseline and Week 6
Change in body fat percentage
Body fat percentage will be measured using bioelectrical impedance analysis (InBody 270). Changes from baseline to Week 6 will be compared between the study groups.
Time frame: Baseline and Week 6
Change in fat-free mass
Fat-free mass will be measured using bioelectrical impedance analysis (InBody 270). Changes from baseline to Week 6 will be compared between the study groups.
Time frame: Baseline and Week 6
Change in lower extremity muscle strength
Lower extremity muscle strength will be assessed using the 30-Second Chair Stand Test. The total number of completed stands within 30 seconds will be recorded and compared between the study groups.
Time frame: Baseline and Week 6
Change in flexibility
Flexibility will be assessed using the Sit-and-Reach Test. The maximum reach distance achieved during the test will be recorded and compared between the study groups.
Time frame: Baseline and Week 6
Plan to share: No
Started May 2026 (actual). Primary completion is estimated for Jan 2027, 8 months after the start.
Of 82 non-industry interventional studies with no phase under Celiac Disease, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 60. This study's planned 8 months is below that.
Counting every sponsor, half of 87 studies reached it within 27 months; a quarter within 12 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.